Proinflammatory role of proteinase‐activated receptor‐2 in humans and mice during cutaneous inflammation in vivo
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Proteinase‐activated receptor‐2 belongs to a new subfamily of G‐protein‐coupled receptors. Its precise role during inflammation and the underlying mechanisms is still unclear. Our study establishes that PAR‐2 plays a direct proinflammatory role during cutaneous inflammation in mice and humans in vivo. In a model of experimentally induced allergic (ACD) and toxic (ICD) contact dermatitis (CD) we show that ear swelling responses, plasma extravasation, and leucocyte adherence were significantly attenuated in PAR‐2 null mutant (PAR‐2 −7− ) mice compared with wild‐type (PAR‐2 +/+ ) mice, especially at early stages. The proinflammatory effects by PAR‐2 activation were significantly diminished using nitric oxide‐synthase inhibitors, while NF‐kappaB and neuropeptides appear to play a minor role in these mechanisms. PAR‐2‐mediated up‐regulation of E‐selectin and cell adhesion molecule ICAM‐1;enhanced plasma extravasation was observed in humans and mice and of interleukin‐6 in mice in vivo. Thus, PAR‐2 may be a beneficial therapeutic target for the treatment of inflammatory skin diseases.— Seeliger, S., Derian, C. K., Vergnolle, N., Bunnett, N. W., Nawroth, R., Schmelz, M., von der Weid, P.‐Y., Buddenkotte, J., Sunderko¨tter, C., Metze, D., Andrade‐ Gordon, P., Harms, E., Vestweber, D., Luger, T. A., Steinhoff, M. Proinflammatory role of proteinase‐activated receptor‐2 in humans and mice during cutaneous inflammation in vivo. FASEB J. 17, 1871–1885 (2003)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946
Cited by
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
COUGHLIN, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01377.x · Cited by 1,035
Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ
Roosterman, D., Goerge, T., Schneider, S. W., Bunnett, N. W., & Steinhoff, M. (2006) · Physiological Reviews · doi:10.1152/physrev.00026.2005 · Cited by 665
Self-citationBriot, A., Deraison, C., Lacroix, M., Bonnart, C., Robin, A., Besson, C., Dubus, P., & Hovnanian, A. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082242 · Cited by 504
Steinhoff, M., Buddenkotte, J., Shpacovitch, V., Rattenholl, A., Moormann, C., Vergnolle, N., Luger, T. A., & Hollenberg, M. D. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0025 · Cited by 501
Self-citationSensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain
Dai, Y., Wang, S., Tominaga, M., Yamamoto, S., Fukuoka, T., Higashi, T., Kobayashi, K., Obata, K., Yamanaka, H., & Noguchi, K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30951 · Cited by 432
Structure, function and pathophysiology of protease activated receptors
Adams, M. N., Ramachandran, R., Yau, M.-K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., & Hooper, J. D. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.003 · Cited by 370
Dai, Y., Moriyama, T., Higashi, T., Togashi, K., Kobayashi, K., Yamanaka, H., Tominaga, M., & Noguchi, K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0454-04.2004 · Cited by 301
Topical Hypochlorous Acid (HOCl) as a Potential Treatment of Pruritus
Pelgrift, R. Y., & Friedman, A. J. (2013) · Current Dermatology Reports · doi:10.1007/s13671-013-0052-z · Cited by 24
Metadata
- Authors
- Seeliger, S., Derian, C. K., Vergnolle, N., Bunnett, N. W., Nawroth, R., Schmelz, M., Von Der Weid, P.-Y., Buddenkotte, J., Sunderkötter, C., Metze, D., Andrade-Gordon, P., Harms, E., Vestweber, D., Luger, T. A., & Steinhoff, M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-10
- Volume
- 17
- Issue
- 13
- Pages
- 1871-1885
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2105643257
- Cited by
- 125
- References
- 1
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.